TELA
TELA Bio, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$1.23
−5.04%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.19
- Revenue estimate
- $20.0M
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.20
- EPS estimate
- -$0.17
- Revenue actual
- $19.3M
- Revenue estimate
- $20.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 5
- EPS misses (12Q)
- 7
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -16.4%
- Revenue beats (12Q)
- 4
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.17 | -$0.20 | Miss -15.10% | $19.3M |
| May 12, 2026 | -$0.14 | -$0.21 | Miss -50.00% | $19.1M |
| Mar 24, 2026 | -$0.18 | -$0.16 | Beat 11.11% | $20.9M |
| Nov 13, 2025 | -$0.17 | -$0.19 | Miss -11.76% | $20.7M |
| May 8, 2025 | -$0.21 | -$0.25 | Miss -19.05% | $18.5M |
| Mar 20, 2025 | -$0.24 | -$0.23 | Beat 4.17% | $17.6M |
| Nov 7, 2024 | -$0.37 | -$0.42 | Miss -13.51% | $19.0M |
| May 9, 2024 | -$0.48 | -$0.23 | Beat 52.08% | $16.6M |
| Mar 21, 2024 | -$0.44 | -$0.53 | Miss -20.45% | $17.0M |
| Nov 9, 2023 | -$0.52 | -$0.45 | Beat 13.46% | $15.1M |
| May 11, 2023 | -$0.51 | -$0.63 | Miss -23.53% | $11.9M |
| Mar 21, 2023 | -$0.58 | -$0.52 | Beat 10.34% | $11.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026